default author photo

Russell J. Schilder

Thomas Jefferson University

1015 Walnut St.

Henry Avenue and School House Lane

Philadelphia, PA 19107

United States

  • Thomas Jefferson University

SCHOLARLY PAPERS

2

DOWNLOADS

77

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

OATH: A Phase II Trial Evaluating the Combination of Onapristone with Anastrozole for Women with Hormone Receptor Positive Endometrial Cancer

Number of pages: 25 Posted: 05 May 2025
Ida Micaily, Mark Shahin, Mitchell Edelson, Norman G. Rosenblum, Ashley Douglas, Saveri Bhattacharya, Tommy R. Buchanan, Tingting Zhan, Tarek Sahmoud, Elizabeth Burton, Avnish Bhatia and Russell J. Schilder
Thomas Jefferson University - Sidney Kimmel Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Thomas Jefferson University, affiliation not provided to SSRN, Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center, affiliation not provided to SSRN, Thomas Jefferson University, affiliation not provided to SSRN, affiliation not provided to SSRN, Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center and Thomas Jefferson University
Downloads 39 (1,196,171)

Abstract:

Loading...

Endometrial cancer, Hormone Receptor, Onapristone, Anastrozole

2.

An Open-Label Study to Determine the Maximum Tolerated Dose of Oral ESK-440 Administered as a Single Agent in Patients with Advanced or Metastatic Solid Tumors

Number of pages: 68 Posted: 28 Dec 2023
Russell J. Schilder, Drew Rasco and Manish Sharma
Thomas Jefferson University, South Texas Accelerated Research Therapeutics and University of Chicago
Downloads 38 (1,209,354)

Abstract:

Loading...

Anaplastic lymphoma kinase (ALK), focal adhesion kinase (FAK), solid tumors, ESK-440, tyrosine kinase inhibitor (TKI)